tirzepatide shortages FDA says the weight-loss drug shortage is over Lilly, Novo Fight Weight Loss

As GLP-1 use grows, understanding their broader impactespecially in T2D patientsis essential

2026, patient information sheet, attached document.[3] Therapeutic Goods Administration (TGA) 2025, ACM meeting statement, Meeting 53, 3 October 2025, TGA.[1] Diabetes Australia 2024, Wegovy to be available in Australia, Diabetes Australia.[4] Hormones Australia 2023, New diabetes drug Mounjaro approved by the TGA, Hormones Australia.[5] Pharmacy Daily 2022, Wegovy gets green light from TGA, Pharmacy Daily.[6] RACGP 2025, Wegovy approved for cutting cardiovascular disease risk, RACGP.[7] Semaglutide-use-and-NAION-risks-with-references.docx

The CREDENCE trial enrolled 4,401 participants with type 2 diabetes mellitus and CKD, with a mean eGFR of 56.2 mL/min/1.73 m 2 and a median urinary albumin-to-creatinine ratio (UACR) of 927 mg/g (Table 1, Fig

Always follow your prescriber's once-weekly schedule and discuss any concerns about tolerability with your PlexusDx provider

It works by slowing down how fast food moves through your stomach, which helps lower your hunger and keeps your blood sugar steady

Any energy improvement comes from better metabolic balance, not a temporary boost